Head-to-Head

Abbott Laboratories vs. Dyne Therapeutics, Inc. Common Stock

ABT

Abbott Laboratories

$104.57 +1.88%

VS DYN

Dyne Therapeutics, Inc. Common Stock

$17.04 +0.35%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTDYN
Market Cap $177.61 billion $3.17 billion

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTDYN
Dividend Yield 2.41% —

ABT and DYN split the dividend factors evenly.

Risk & Sentiment

ABTDYN
Short Interest 0.57% 11.72%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, DYN overview, DYN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.